QIAGEN expands syndromic diagnostic portfolio to Singapore

QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel, a qualitative multiplexed nucleic acid-based in vitro diagnostic...

February 7, 2024 | Wednesday | News
Singapore's Qritive drives AI adoption in pathology and diagnosis across India

Singapore headquartered QritiveTM, a leading provider of AI solutions for pathology labs worldwide, has partnered w...

February 6, 2024 | Tuesday | News
Singapore develops new programme to assist in early breast cancer detection

A group of researchers, led by Assoc Prof Ng Yin Kwee from NTU’s School of Mechanical and Aerospace Engineering (M...

February 7, 2024 | Wednesday | News
Labcorp launches new test for risk assessment and prognosis of severe preeclampsia in pregnant women

Labcorp, a global leader of innovative and comprehensive laboratory services, has announced the launch and availability ...

February 1, 2024 | Thursday | News
“AI's superior speed & learning capability make it a natural fit for healthcare tasks demanding precision & early detection”

How did VinBrain come into existence?  After 26 years abroad, spending 13 years as the Director of Engineering and...

February 1, 2024 | Thursday | Opinion
BD, Techcyte to offer AI-based digital cervical cytology system for pap testing

BD (Becton, Dickinson and Company), US-based medical technology company, and Techcyte, a world leader in artificial inte...

January 31, 2024 | Wednesday | News
Agilent partners with Incyte to develop advanced companion diagnostics in haematology and oncology

American firm Agilent Technologies Inc. has announced an agreement with US-based Incyte, an American...

January 31, 2024 | Wednesday | News
Researchers in Korea develop sweat resistant wearable robot sensor​

New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affe...

January 30, 2024 | Tuesday | News
Korea's Seegene enhances automated diagnostic reagent development system with Microsoft

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has announced its...

January 25, 2024 | Thursday | News
Fujirebio & Agappe ink business collaboration for CLIA based immunoassay products

Japan-based Fujirebio Holdings and Indian firm Agappe Diagnostics have entered into an agreement of Contract Development...

January 22, 2024 | Monday | News
Lord's Mark Industries targets export of 6.55 M+ diagnostic supplies to SAARC countries

With the recent launch of Export Division for diagnostic supplies by LordsMed, the global healthcare division of India-b...

January 19, 2024 | Friday | News
Australia approves Immunexpress' sepsis diagnostic device

Immunexpress,  a molecular diagnostic company based in Brisbane and Seattle, has announced that Sept...

January 18, 2024 | Thursday | News
Orbis International & NIDEK scale up AI-based eye screenings in Vietnam

Orbis International has announced an important in-kind and financial donation from NIDEK to support Orbis's ar...

January 16, 2024 | Tuesday | News
Malaysia-based medical device firm Mediven partners with Caring Pharmacy Group

Medical Innovation Ventures Sdn. Bhd. (Mediven), a leading Malaysian-based medical device company, has collaborated with...

January 15, 2024 | Monday | News
Japan approves first at-home migraine treatment in the form of Neurolief's neuromodulation device

US-based Neurolief has announced the approval of its neuromodulation device, Relivion, by the Japanese Ministry of Healt...

January 10, 2024 | Wednesday | News
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test

American firm Illumina Inc., a global leader in DNA sequencing and array-based technologies, has signed an agreement wit...

January 5, 2024 | Friday | News
Japan introduces world's first machine learning model to screen Alzheimer's disease

Japan-based Oita University and pharmaceutical firm Eisai Co. have announced the development of the world's first machin...

January 2, 2024 | Tuesday | News
Roche buys LumiraDx’s Point-of-Care technology for more than $300 M

Swiss firm Roche has announced the entry into a definitive agreement to acquire select parts of the UK-based LumiraDx gr...

December 31, 2023 | Sunday | News